A small molecule drug candidate fully restores survival in a lethal mouse model of a rare kidney stone disease that has no current treatment - EurekAlert!
Monoclonal antibody benralizumab, given during some asthma and COPD attacks, is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%.
